Invus Financial Advisors’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $6.01M | Hold |
|
|||||
|
2024
Q1 | $5.48M | Hold |
|
|||||
|
2023
Q4 | $5.24M | Hold |
|
|||||
|
2023
Q3 | $5.67M | Hold |
|
|||||
|
2023
Q2 | $14.6M | Hold |
|
|||||
|
2023
Q1 | $21.1M | Hold |
|
|||||
|
2022
Q4 | $25.7M | Hold |
|
|||||
|
2022
Q3 | $26.7M | Hold |
|
|||||
|
2022
Q2 | $24.4M | Hold |
|
|||||
|
2022
Q1 | $29.1M | Hold |
|
|||||
|
2021
Q4 | $26.3M | Hold |
|
|||||
|
2021
Q3 | $40.8M | Hold |
|
|||||
|
2021
Q2 | $77.8M | Hold |
|
|||||
|
2021
Q1 | $46.4M | Hold |
|
|||||
|
2020
Q4 | $60.7M | Hold |
|
|||||
|
2020
Q3 | $39.1M | Sell |
|
|||||
|
2020
Q2 | $27.9M | Hold |
|
|||||
|
2020
Q1 | $31.7M | Hold |
|
|||||
|
2019
Q4 | $39.7M | Buy |
|